Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Stress Response and Neurodevelopment in Pediatric Cardiac Surgery
NCT02492269Phase 2Completed
- Start
- May 2014
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in congenital heart disease (CHD) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoints: Change in Cytokine Levels at 24 hours, Change in Hormone Levels at 24 hours and 1 more. Started May 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT02492269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492269.